Navigation Links
Advanced Prostate Cancer Patients Finally Have Another Option
Date:4/29/2010

WASHINGTON, April 29 /PRNewswire-USNewswire/ -- Today is an exciting day for men with advanced prostate cancer and the millions of families and loved ones who are profoundly affected. Today a new prostate cancer treatment option, Provenge, was approved by the Food and Drug Administration (FDA).

Men's Health Network (MHN) is excited to see this innovative treatment option made available for patients with asymptomatic or minimally symptomatic metastatic castrate-resistant (hormone refractory) prostate cancer. Provenge harnesses the individual's own immune system to fight cancer through a process called active cellular immunotherapy.

Provenge offers hope for men (and their families) to potentially extend and improve the quality of life for those who are suffering from advanced prostate cancer.  Patients should work with their healthcare providers to determine if they are an appropriate candidate for Provenge at this time.

There is an immense need for more options and awareness about the plight of men with advanced prostate cancer. MHN is very excited that the approval of Provenge brings us one step closer to this goal by adding a breakthrough treatment option for these men.  Men now have an opportunity to engage in a conversation with their health care provider about this new innovative immunotherapy to potentially extend and improve their quality of life.

For more information about prostate cancer, please visit www.menshealthnetwork.org or call us at 866-543-6461, extension 101.

About Men's Health Network

Men's Health Network (www.menshealthnetwork.org) is a national non-profit organization whose mission is to reach men and their families where they live, work, play, and pray with health prevention messages and tools, screening programs, educational materials, advocacy opportunities, and patient navigation.


'/>"/>
SOURCE Men's Health Network
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. FDA Approves PROVENGE(R) for the Treatment of Men with Advanced Prostate Cancer
2. The Wellcore System Begins Shipping Featuring the Most Advanced Automatic Fall Detection Available
3. MicroMass Named Agency of Record for North Carolina Advanced Medical Technologies Center of Innovation
4. Once-Daily MIRAPEX ER Now Approved by FDA for Both Early and Advanced Parkinsons Disease
5. VIDEO from Medialink and LSI: Advanced Technologies Make Science More Accessible
6. Abbott Seeks FDA Approval of a New Six-Month 45-mg Formulation of Lupron(R) Depot for the Palliative Treatment of Advanced Prostate Cancer
7. FDA Approves Watsons TRELSTAR(R) 22.5 mg, the First and Only 6-Month Intramuscular GnRH Agonist for the Palliative Treatment of Advanced Prostate Cancer
8. Advanced Life Sciences Announces 2009 Fourth Quarter and Full Year Financial Results
9. Advanced Life Sciences to Host 2009 Fourth Quarter and Full Year Financial Results Conference Call and Webcast
10. UAB Hospital to Integrate Advanced Symbiq(TM) Infusion Device With EHR to Enhance Safety and Clinician Workflow
11. Ferring Pharmaceuticals and Gene Security Network Partner to Test Advanced Preimplantation Genetic Diagnosis (PGD) Technology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/7/2017)... Inc. (NYSE: DPLO), the nation,s largest independent specialty pharmacy, announced ... comparisons, unless otherwise noted, are to the quarter ended June ... Quarter 2017 Highlights include: Revenue of ... Total prescriptions dispensed of 220,000, compared to ... Gross profit per prescription dispensed of ...
(Date:8/3/2017)...  Opioid addiction and other drugs of abuse, blood ... threatening outcomes, were problems taken on directly as laboratory ... support them, met this week. This according to Kalorama ... of abuse, procalcitonin and acute kidney injury were key ... meeting in San Diego, CA. ...
(Date:8/2/2017)... Aug. 2, 2017 CaryRx, a next-generation full-service pharmacy, ... service for patients in the Washington D.C. ... pharmacy by providing delivery of medications through the convenience of ... delivery or delivered within one hour to any location in ... to bring this invaluable service to Washington D.C. ...
Breaking Medicine Technology:
(Date:8/18/2017)... ... 2017 , ... “Kingdom Mandate for Kingdom Builders”: a call to walk as ... Builders” is the creation of published author, John F. McGeorge, Jr. Dr. John ... in 1983. He spent three decades training pastors and Christian leaders. He ...
(Date:8/18/2017)... ... 2017 , ... “Steve the Snake”: an entertaining and moral-based short story about ... published author, Harold Flash Haskins Jr., a husband, father and grandfather who served as ... “I write moral-based short stories for children and teens. My goal is to teach ...
(Date:8/17/2017)... (PRWEB) , ... August 17, 2017 , ... ... practice, is adding a new location in Goldsboro, NC to its family of ... that is Riccobene Associates’ trademark starting August 15, 2017. , Riccobene Associates ...
(Date:8/17/2017)... ... August 17, 2017 , ... The award-winning producers ... feature the National Council for Therapeutic Recreation Certification (NCTRC), slated to air nationwide, ... 1981, NCTRC is a non-profit, international organization dedicated to professional excellence for the ...
(Date:8/17/2017)... Boston, MA (PRWEB) , ... August 17, 2017 ... ... investors will come together on September 19, 2017 for Anti-Infectives Rx. This off-the-record ... Joseph B. Martin Conference Center at Harvard Medical School. , Industry leaders and ...
Breaking Medicine News(10 mins):